Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹52 Cr₹48 Cr₹37 Cr₹6.13 Cr₹197 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹52 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹52 Cr
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr
Mar2020₹197 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹52 Cr
7.39
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr
-96.88
Mar2020 ₹197 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹270.6 Cr -2.1% -5.7% -56.7% Stock Analytics
ADANI ENTERPRISES ₹298,183.0 Cr -0.3% 3.1% -17.3% Stock Analytics
REDINGTON ₹24,086.5 Cr 0.3% 4.4% 43.4% Stock Analytics
LLOYDS ENTERPRISES ₹11,328.3 Cr 1.2% 20.5% 124% Stock Analytics
MMTC ₹10,176.0 Cr -2.2% -2.5% -17.8% Stock Analytics
HONASA CONSUMER ₹9,415.7 Cr -2.7% -5.7% -37.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.1%

-5.7%

-56.7%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses